These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8158348)

  • 1. Effect of cicaprost on the progression of diabetic nephropathy in uninephrectomized streptozotocin-induced diabetic rats.
    Robles RG; Villa E; Rábano A; Alvarez E; Martínez J; Ruilope LM; Sancho JM
    J Hypertens Suppl; 1993 Dec; 11(5):S208-9. PubMed ID: 8158348
    [No Abstract]   [Full Text] [Related]  

  • 2. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters.
    Abo-Salem OM; El-Edel RH; Harisa GE; El-Halawany N; Ghonaim MM
    Pak J Pharm Sci; 2009 Apr; 22(2):205-10. PubMed ID: 19339234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclo-oxygenase-2 inhibition attenuates the progression of nephropathy in uninephrectomized diabetic rats.
    Komers R; Lindsley JN; Oyama TT; Anderson S
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):36-41. PubMed ID: 17201733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rodent models of streptozotocin-induced diabetic nephropathy.
    Tesch GH; Allen TJ
    Nephrology (Carlton); 2007 Jun; 12(3):261-6. PubMed ID: 17498121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats.
    Lloberas N; Cruzado JM; Franquesa M; Herrero-Fresneda I; Torras J; Alperovich G; Rama I; Vidal A; Grinyó JM
    J Am Soc Nephrol; 2006 May; 17(5):1395-404. PubMed ID: 16597691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory effect of bitter gourd (Momordica charantia LINN.) on alterations in kidney heparan sulfate in streptozotocin-induced diabetic rats.
    Kumar GS; Shetty AK; Salimath PV
    J Ethnopharmacol; 2008 Jan; 115(2):276-83. PubMed ID: 18024034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyphenolic extract of Ichnocarpus frutescens attenuates diabetic complications in streptozotocin-treated diabetic rats.
    Kumarappan CT; Mandal SC
    Ren Fail; 2008; 30(3):307-22. PubMed ID: 18350451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pyridoindole antioxidant stobadine attenuates albuminuria, enzymuria, kidney lipid peroxidation and matrix collagen cross-linking in streptozotocin-induced diabetic rats.
    Stefek M; Gajdosik A; Tribulova N; Navarova J; Volkovova K; Weismann P; Gajdosikova A; Drimal J; Mihalova D
    Methods Find Exp Clin Pharmacol; 2002 Nov; 24(9):565-71. PubMed ID: 12616702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of polyphenol-containing azuki bean (Vigna angularis) seed coats on the renal cortex in streptozotocin-induced diabetic rats.
    Sato S; Yamate J; Hori Y; Hatai A; Nozawa M; Sagai M
    J Nutr Biochem; 2005 Sep; 16(9):547-53. PubMed ID: 16115543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol extraction of Picrorhiza scrophulariiflora prevents renal injury in experimental diabetes via anti-inflammation action.
    He LJ; Liang M; Hou FF; Guo ZJ; Xie D; Zhang X
    J Endocrinol; 2009 Mar; 200(3):347-55. PubMed ID: 19066289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.
    Liu IM; Tzeng TF; Liou SS; Chang CJ
    J Ethnopharmacol; 2009 Jul; 124(2):211-8. PubMed ID: 19397971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of renoinflammatory cascade in experimental model of diabetic nephropathy by sesamol.
    Kuhad A; Sachdeva AK; Chopra K
    J Agric Food Chem; 2009 Jul; 57(14):6123-8. PubMed ID: 19601660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential prophylactic role of aminoguanidine in diabetic retinopathy and nephropathy in experimental animals.
    El Shazly AH; Mahmoud AM; Darwish NS
    Acta Pharm; 2009 Mar; 59(1):67-73. PubMed ID: 19304559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin prevents early steps of the development of diabetic nephropathy in rats.
    Yang Y; Wang J; Qin L; Shou Z; Zhao J; Wang H; Chen Y; Chen J
    Am J Nephrol; 2007; 27(5):495-502. PubMed ID: 17671379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway.
    Kuhad A; Chopra K
    Life Sci; 2009 Feb; 84(9-10):296-301. PubMed ID: 19162042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal moncyte chemoattractant protein-1 expression.
    Zheng M; Ye S; Zhai Z; Chen Y; Li X; Yang G; Fan A; Wang Y
    J Diabetes Complications; 2009; 23(2):124-9. PubMed ID: 18413206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental treatment of complications in alloxan diabetic rats with alpha-glucosidase inhibitor from the Chinese medicinal herb ramulus mori.
    Ye F; Shen ZF; Qiao FX; Zhao DY; Xie MZ
    Yao Xue Xue Bao; 2002 Feb; 37(2):108-12. PubMed ID: 12579953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic endothelin B receptor-deficient rats develop severe hypertension and progressive renal failure.
    Pfab T; Thöne-Reineke C; Theilig F; Lange I; Witt H; Maser-Gluth C; Bader M; Stasch JP; Ruiz P; Bachmann S; Yanagisawa M; Hocher B
    J Am Soc Nephrol; 2006 Apr; 17(4):1082-9. PubMed ID: 16495378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotective effects of fenofibrate in diabetic rats are achieved by suppressing kidney plasminogen activator inhibitor-1.
    Chen LL; Zhang JY; Wang BP
    Vascul Pharmacol; 2006 May; 44(5):309-15. PubMed ID: 16624630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.